BEYOND THE GUT: THE IMPORTANCE OF CONTROLLING SYSTEMIC INFLAMMATION IN INFLAMMATORY BOWEL DISEASE Summary of presentations from the AbbVie-Sponsored Symposium on Inflammatory Bowel Disease, held at the 11th Congress of the European Crohn’s and Colitis Organisation

Disclosure: Yehuda Chowers has received consulting/lecture fees from AbbVie, Janssen, Takeda, and Protalix. Remo Panaccione is a consultant for AbbVie/Abbott, Amgen, Aptalis, AstraZeneca, Baxter, Bristol-Myers Squibb, Celgene, Cubist, Eisai, Ferring, Gilead, Janssen, Merck, Robarts, Salix, Samsung, Shire, Centocor, Elan, GlaxoSmithKline, UCB, Pfizer, and Takeda; has participated in speaker bureaux for Abbvie/Abbott, Aptalis, AstraZeneca, Ferring, Janssen, Merck, Prometheus, Shire, and Takeda; and advisory boards for AbbVie, Abbott, Amgen, Aptalis, AstraZeneca, Baxter, Eisai, Ferring, Genentech, Jansen, Merck, Schering-Plough, Shire, Centocor, Elan, GlaxoSmithKline, UCB, Pfizer, Bristol-Myers Squibb, Takeda, Cubist, Celgene, and Salix; and has received research/educational support from AbbVie/Abbott, Ferring, Janssen, and Takeda. Geert D’Haens is an advisor for AbbVie, Ablynx, Amakem, AM Pharma, Avaxia, Biogen, Bristol Meiers Squibb, Boerhinger Ingelheim, Celgene, Celltrion, Cosmo, Covidien, Ferring, DrFALK Pharma, Engene, Ferring, Galapagos, Gilead, GlaxoSmithKline, Hospira, Johnson and Johnson, Medimetrics, Millenium/Takeda, Mitsubishi Pharma, Merck Sharp Dome, Mundipharma, Novonordisk, Pfizer, Prometheus laboratories/Nestlé, Receptos, Robarts Clinical Trials, Salix, Sandoz, Setpoint, Shire, Teva, Tigenix, Tillotts, Topivert, Versant, and Vifor and received speaker fees from AbbVie, Ferring, Johnson and Johnson, Merck Sharp Dome, Mundipharma, Norgine, Pfizer, Shire, Millenium/Takeda, Tillotts, and Vifor; and has received speaker fees from Abbvie, Ferring, Jansen Biologics, Merck Sharp & Dohme, Mundipharma, Norgine, Shire, Takeda, Tillotts, UCB, and Vifor. Acknowledgements: Writing assistance was provided by Jackie Phillipson, PhD, CMPP, at Ashfield Healthcare Communications Ltd. Support: The publication of this article was funded by AbbVie. The views and opinions expressed are those of the speakers and not necessarily of AbbVie. Citation: EMJ Gastroenterol. 2016;5[Suppl 7]:2-10